Profiel
Mario Alberto Accardi currently works at Centessa Pharmaceuticals (Orexia) Ltd., as Director and Sierra MedTech Ltd., as Director from 2013.
Dr. Accardi also formerly worked at Centessa Pharmaceuticals Plc, as Chief Executive Officer & Director in 2026, Aitia, Inc., as Director, Inexia Ltd., as Director, vasopharm GmbH, as Member-Supervisory Board, and Entrepreneurs Fund Management LLP, as Associate.
Dr. Accardi received his graduate degree and doctorate degree from Imperial College London.
Actieve functies van Mario Alberto Accardi
| Bedrijven | Functie | Begin |
|---|---|---|
Orexia Therapeutics Ltd.
Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops orally orexin positive modulators for the treatment of neurological diseases | Directeur/Bestuurslid | 02-01-2019 |
Sierra MedTech Ltd.
Sierra MedTech Ltd. Medical SpecialtiesHealth Technology Operates as a medical technology company which focuses on the development of innovative orthopaedic solutions | Directeur/Bestuurslid | 03-06-2013 |
Eerdere bekende functies van Mario Alberto Accardi
| Bedrijven | Functie | Einde |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Algemeen Directeur | 24-06-2026 |
Inexia Ltd.
Inexia Ltd. Medical SpecialtiesHealth Technology Develops intranasal positive modulators | Directeur/Bestuurslid | - |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases | Directeur/Bestuurslid | - |
Aitia, Inc.
Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides analytics solutions for the healthcare industry | Directeur/Bestuurslid | - |
Entrepreneurs Fund Management LLP
Entrepreneurs Fund Management LLP Investment ManagersFinance Entrepreneurs Fund invests in companies located primarily in Western Europe. The firm targets companies operating in the fields of life sciences and technology. It provides financing from seed to pre-IPO stages with an investment size of EUR 250k – 10 million. | Private Equity Analist | - |
Opleiding van Mario Alberto Accardi
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Aitia, Inc.
Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides analytics solutions for the healthcare industry | Commercial Services |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases | Health Technology |
Entrepreneurs Fund Management LLP
Entrepreneurs Fund Management LLP Investment ManagersFinance Entrepreneurs Fund invests in companies located primarily in Western Europe. The firm targets companies operating in the fields of life sciences and technology. It provides financing from seed to pre-IPO stages with an investment size of EUR 250k – 10 million. | Finance |
Inexia Ltd.
Inexia Ltd. Medical SpecialtiesHealth Technology Develops intranasal positive modulators | Health Technology |
Orexia Therapeutics Ltd.
Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops orally orexin positive modulators for the treatment of neurological diseases | Commercial Services |
Centessa Pharmaceuticals Plc
Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
Sierra MedTech Ltd.
Sierra MedTech Ltd. Medical SpecialtiesHealth Technology Operates as a medical technology company which focuses on the development of innovative orthopaedic solutions | Health Technology |
















